The Goldman Sachs Group Cuts Teladoc Health (NYSE:TDOC) Price Target to $13.00

Teladoc Health (NYSE:TDOC) had its target price reduced by The Goldman Sachs Group from $16.00 to $13.00 in a report issued on Monday,Benzinga reports. They currently have a buy rating on the health services provider’s stock.

TDOC has been the topic of several other reports. Bank of America lifted their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Piper Sandler decreased their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Finally, Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.26.

Teladoc Health Trading Down 1.6 %

Teladoc Health stock opened at $9.06 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of -1.57 and a beta of 1.27. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.95. The firm’s 50 day moving average price is $10.63 and its two-hundred day moving average price is $9.62.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. On average, research analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new position in Teladoc Health in the 4th quarter worth $29,000. Versant Capital Management Inc raised its holdings in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the period. Lindbrook Capital LLC raised its holdings in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after acquiring an additional 1,612 shares during the period. Sterling Capital Management LLC raised its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after acquiring an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in Teladoc Health in the 4th quarter worth $60,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.